Relationship of circulating tumor DNA (ctDNA) tumor fraction with prognosis in patients with metastatic pancreatobiliary cancer

被引：0
|
作者：
Pathak, Priyadarshini
Li, Gerald
Quintanilha, Julia
Keller-Evans, Rachel B.
Pasquina, Lincoln W.
Thierauf, Julia
Elvin, Julia A.
Ross, Jeffrey S.
Graf, Ryon P.
Parikh, Aparna Raj
Pishvaian, Michael J.
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Fdn Med Inc, Boston, MA USA
[3] Fdn Med Inc, Cambridge, MA USA
[4] Fdn Med Inc, San Diego, CA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA USA
[6] Johns Hopkins Univ, Dept Pediat, Sch Med Washington, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.763
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
763
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer
    Pathak, Priyadarshini
    Li, Gerald
    Quintanilha, Julia
    Keller, Rachel Beth
    Pasquina, Lincoln
    Thierauf, Julia
    Graf, Ryon
    Parikh, Aparna Raj
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 621 - 621
  • [2] Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with advanced urothelial cancer
    Miron, B.
    Li, G.
    Clark, A.
    Pasquina, L.
    Graf, R. P.
    Oxnard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1220 - S1220
  • [3] Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer
    Davis, Andrew A.
    Jacob, Saya
    Gerratana, Lorenzo
    Shah, Ami N.
    Wehbe, Firas
    Katam, Neelima
    Zhang, Qiang
    Flaum, Lisa
    Siziopikou, Kalliopi
    Platanias, Leonidas C.
    Gradishar, William J.
    Behdad, Amir
    Cristofanilli, Massimo
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Clinical application of circulating tumor DNA (ctDNA) in patients with metastatic gastric cancer.
    Hong, Moonki
    Lee, Kwang Seob
    Park, Sejung
    Kim, Kyoo Hyun
    Kim, Hyunwook
    Che, Jingmin
    Kwon, Woo Sun
    Lee, Choong-kun
    Jung, Minkyu
    Chung, Hyun Cheol Cheol
    Shin, Saeam
    Lee, Seung-Tae
    Choi, Jong Rak
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 441 - 441
  • [5] Utility of circulating tumor DNA (ctDNA) to inform treatment of patients with metastatic breast cancer
    Linville, Laura Meili
    Canzoniero, Jenna VanLiere
    Too, Faith
    Lombardo, Alexandra
    Malwankar, Jui
    Mawalkar, Resham
    Haile, Meron
    Zandi, Lily
    Babu, Vidya
    Brown, Derek W.
    Xu, Chang
    Boyle, Patrick
    Pasquina, Lincoln W.
    Santa-Maria, Cesar Augusto
    Tao, Jessica
    Bayable, Asnakech
    Greenberg, Larisa
    Anagnostou, Valsamo
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) longitudinal monitoring of metastatic breast cancer (MBC).
    Costa, Ricardo Lima Barros
    Rossi, Giovanna
    Mu, Zhaomei
    Austin, Laura Katherine
    Rademaker, Alfred
    Gradishar, William John
    Santa-Maria, Cesar Augusto
    Jain, Sarika
    Flaum, Lisa E.
    Giles, Francis J.
    Yang, Hushan
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC)
    Nguyen, Charles B.
    Tsung, Irene
    Lee, Jessica K.
    Pasquina, Lincoln W.
    Kasputis, Amy
    Lovett, Jennie L.
    Graf, Ryon P.
    Cackowski, Frank Cameron
    Heath, Elisabeth I.
    Morgan, Todd Matthew
    Reichert, Zachery R.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Clinical utility of circulating tumor DNA (ctDNA) in advanced and metastatic breast cancer
    Austin, Laura K.
    Jaslow, Rebecca
    Avery, Tiffany
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
  • [9] Predictors for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
    Pereira, Allan Andresson Lima
    Loree, Jonathan M.
    Davis, Jennifer S.
    Lam, Michael
    Morris, Van Karlyle
    Overman, Michael J.
    Raghav, Kanwal Pratap Singh
    Kee, Bryan K.
    Fogelman, David R.
    Sanchez, Eduardo Vilar
    Shureiqi, Imad
    Eng, Cathy
    Manuel, Shanequa
    Crosby, Shadarra
    Wolff, Robert A.
    Lanman, Richard B.
    Talasaz, AmirAli
    Janku, Filip
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] Impact of a metastatic site on circulating tumor DNA (ctDNA) analysis in patients (pts) with metastatic colorectal cancer (mCRC).
    Bando, Hideaki
    Nakamura, Yoshiaki
    Taniguchi, Hiroya
    Shiozawa, Manabu
    Yasui, Hisateru
    Esaki, Taito
    Ohta, Takashi
    Denda, Tadamichi
    Satoh, Taroh
    Yamazaki, Kentaro
    Sunakawa, Yu
    Kato, Takeshi
    Goto, Masahiro
    Yuki, Satoshi
    Nishina, Tomohiro
    Oki, Eiji
    Shinozaki, Eiji
    Matsuhashi, Nobuhisa
    Hata, Masayuki
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345